兔抗小鼠IgG-FC免疫血清抗體本公司提供的熒光抗體是將抗血清,經(jīng)純化成抗體IgG成分,采用直接標(biāo)記方法,將異硫氰酸熒光素(FITC美國(guó)sigma產(chǎn)品)及異硫氰酸羅達(dá)明熒光素(紅色)(RBITC, sigma產(chǎn))共價(jià)交聯(lián)到抗體(IgG)分子的賴氨酸分子上,并經(jīng)過純化、蛋白量、FITC、RBITC濃度及效價(jià)鑒定而制成。 兔抗小鼠IgG-FC免疫血清抗體應(yīng)用范圍: 1.用于細(xì)菌、病毒、梅毒螺旋體、鉤端螺旋體等微生物的抗原或抗體檢查。 2.用于臨床自身免疫病的多種自身抗體熒光檢查,如抗核抗體,抗心肌抗體等。 3.細(xì)胞因子等檢查的熒光流式細(xì)胞儀測(cè)定。 4.白細(xì)胞分型抗原的免疫熒光染色。 5.免疫組織及免疫病理中抗原,抗體檢查,如各種腫瘤抗原檢查。 主要性能:每支0.5ml液體,含有0.03%NaN3防腐,IgG蛋白,濃度在5mg左右,F(xiàn)ITC為sigma異構(gòu)體I,約在70?80μg/ml,495nm為zui大吸收峰。RBITC約20?40μg/mlzui大吸收555nm,zui大熒光光譜波長(zhǎng)為600nm。工作濃度用0.01mol/LpH7.4PBS作1:10?1:20稀釋使用,-20℃可保存一年,盡量少反復(fù)凍融。通稱第二抗體。 保存條件: -20°C 兔抗小鼠IgG-FC免疫血清抗體公司其他優(yōu)勢(shì)產(chǎn)品:Human sphingomyelin,SM Rat matrix metalloproteinase 5,MMP-5 Human sphingomyelin,SM Human Sialic acid,SA Human matrix metalloproteinase 5,MMP-5 Human Sialic acid,SA Human amiodarone,AD rabbit matrix metalloproteinase 5,MMP-5 Human amiodarone,AD Human lipoteichoic acids,LTA Rat matrix metalloproteinase 7,MMP-7 Human lipoteichoic acids,LTA Human β-lipotropic hormone,β-LPH Human Matrix metalloproteinase 7,MMP-7 Human β-lipotropic hormone,β-LPH Human proteinase-antineutrophil cytoplasmic antibody,PR3-ANCA Rat matrix metalloproteinase 8/Neutrophil collagenase,MMP-8 Human proteinase-antineutrophil cytoplasmic antibody,PR3-ANCA Human Lipoxin A4,LXA4 Human Matrix metalloproteinase 8/Neutrophil collagenase,MMP-8 Human Lipoxin A4,LXA4 Human Stromelysin-3,ST3 Human matrix metalloproteinase 9/Gelatinase B,MMP-9 Human Stromelysin-3,ST3 Human Stromelysin-2,ST2 rabbit matrix metalloproteinase 9,MMP-9 Human Stromelysin-2,ST2 Human Stromelysin-1,ST1 guinea pig matrix metalloproteinase 9,MMP-9 Human Stromelysin-1,ST1 Human orphanin FQ/nociceptin,OFQ/N Porcine matrix metalloproteinase 9,MMP-9 Human orphanin FQ/nociceptin,OFQ/N Human Na+/H+ exchanger 3,NHE3 Human melanoma metastasis surface adhesion molecule,MMSAM Human Na+/H+ exchanger 3,NHE3 Human lumican,LUM Porcine melanoma metastasis surface adhesion molecule,MMSAM Human lumican,LUM Human 2,3-Disphosphoglycerate,2,3-DPG Human metanephrine,MN Human 2,3-Disphosphoglycerate,2,3-DPG Human CCAAT/enhancer binding protein alpha,C/EBPα Human Mannose,MN Human CCAAT/enhancer binding protein alpha,C/EBPα Human CCAAT/enhancer binding protein deta,C/EBPδ Rat Oncostatin-M,OSM Human CCAAT/enhancer binding protein deta,C/EBPδ Human CCAAT/enhancer binding protein epsilon,C/EBPε Rabbit Oncostatin-M,OSM Human CCAAT/enhancer binding protein epsilon,C/EBPε Human soluble endothelial protein C receptor,sEPCR Human Mycoplasma pneumoniae antibody,MP-Ab Human soluble endothelial protein C receptor,sEPCR Human Protein S Human maturation promoting factor,MPF Human Protein S Human Protein Z Human Myeloid Progenitor Inhibitory Factor 1,MPIF-1 Human Protein Z Human nonmethylated oligonucleotide,NON Rat myeloperoxidase-antineutrophil cytoplasmic antibody IgG,MPO-ANCA IgG Human nonmethylated oligonucleotide,NON Human ICE protease-activating factor,IRAP Human Mouse myeloperoxidase-antineutrophil cytoplasmic antibody IgG,MPO-ANCA IgG Human ICE protease-activating facto |